Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04712942
Title Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Leipzig
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Azacitidine + MLN4924

Azacitidine

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.